Thursday, March 19, 2026 3/19/2026

Effectiveness and Mechanisms of Multilevel Implementation Strategies to Improve Cancer Prevention Behaviors: A Cluster Randomized Trial

Award Number: R01CA255872
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/15/2021
PERIOD OF PERFORMANCE END DATE: 06/30/2026

Group Awards By:

View Award Description

Effectiveness and Mechanisms of Multilevel Implementation Strategies to Improve Cancer Prevention Behaviors: A Cluster Randomized Trial - Cancer is a critical national health issue with over 2 million new cancer diagnoses annually within the U.S. and over 600,000 cancer-related deaths. Preventive actions from childhood and adolescence holds great promise in preventing cervical, anal, penile, vaginal, vulvar, and oropharyngeal cancer later in adult life. Yet, little is known about how to leverage this and other facilitators of cancer prevention behaviors in adolescents. Additionally, studies have also revealed multilevel, multifactorial barriers to improving cancer prevention recommendations and critical limitations of health system support. Despite this knowledge, many prior cancer prevention studies in adolescents focus on single-level, single component interventions, leaving many barriers unaddressed. Of studies that are multilevel and/or multi-component, interventions are often pre-selected to address “typical” barriers but are not responsive to unique local barriers and local context. To address this critical gap, we propose a 3-arm cluster randomized controlled trial (RCT) to compare implementation strategies that are multilevel and multicomponent and guided by in-depth understanding of how multilevel factors in the practice settings modify the impact of key facilitators. We will use mixed methods (surveys, interviews, electronic health records) throughout; initially we will evaluate baseline associations between patient-, provider-, and clinic-level factors and variations in cancer prevention behaviors in children and adolescents (Aim 1). In Aim 2, we will compare the effectiveness of: 1) A novel “local-tailored” implementation strategy, co-designed with local care teams to address local barriers and contexts; versus 2) A “prescribed” strategy, typical of most health systems, that involves pre-specified interventions addressing pre-selected cancer prevention barriers; versus 3) Usual care. We will evaluate the effectiveness of these strategies on improving cancer prevention behaviors (primary outcome). Although the need for local tailoring may seem intuitive, it is unknown if local tailoring will yield superior outcomes that could offset the extra investment required, supporting the need for this RCT. We will conduct the study within Kaiser Permanente Southern California, one of the largest community-based care organizations in the U.S. Our study will be guided by the Consolidated Framework for Implementation Research and the Multilevel Factors Across the Cancer Care Continuum framework. Completion of these Aims will generate important insights into the multilevel factors associated with cancer prevention in children and adolescents. This study has high potential to generate critical guidance for diverse health care settings to improve cancer prevention behaviors, ultimately leading to fewer diagnoses of new cancers across the U.S.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $612,449 )
2025	2025	KAISER FOUNDATION HOSPITALS	1800 HARRISON ST FL 16	OAKLAND	CA	94612	ALAMEDA	USA	Cancer Cause and Prevention Research	000	5	8/27/2025	NON-COMPETING CONTINUATION	$612,449
														Subtotal = $612,449

Issue Date FY: 2024 ( Subtotal = $593,242 )
2024	2024	KAISER FOUNDATION HOSPITALS	1800 HARRISON ST FL 16	OAKLAND	CA	94612	ALAMEDA	USA	Cancer Cause and Prevention Research	000	4	8/16/2024	NON-COMPETING CONTINUATION	$593,242
2024	2024	KAISER FOUNDATION HOSPITALS	1800 HARRISON ST FL 16	OAKLAND	CA	94612	ALAMEDA	USA	Cancer Cause and Prevention Research	001	4	9/26/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $593,242

Issue Date FY: 2023 ( Subtotal = $627,341 )
2023	2023	KAISER FOUNDATION HOSPITALS	1800 HARRISON ST FL 16	OAKLAND	CA	94612	ALAMEDA	USA	Cancer Cause and Prevention Research	000	3	7/6/2023	NON-COMPETING CONTINUATION	$627,341
														Subtotal = $627,341

Issue Date FY: 2022 ( Subtotal = $649,552 )
2022	2022	KAISER FOUNDATION HOSPITALS	1800 HARRISON ST FL 16	OAKLAND	CA	94612	ALAMEDA	USA	Cancer Cause and Prevention Research	000	2	6/20/2022	NON-COMPETING CONTINUATION	$649,552
														Subtotal = $649,552

Issue Date FY: 2021 ( Subtotal = $691,976 )
2021	2021	KAISER FOUNDATION HOSPITALS	1800 HARRISON ST FL 16	OAKLAND	CA	94612	ALAMEDA	USA	Cancer Cause and Prevention Research	000	1	7/14/2021	NEW	$691,976
														Subtotal = $691,976

Grand Total All Awards = $3,174,560

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Effectiveness and Mechanisms of Multilevel Implementation Strategies to Improve Cancer Prevention Behaviors: A Cluster Randomized Trial

Award Number: R01CA255872

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/15/2021

PERIOD OF PERFORMANCE END DATE: 06/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer